Consistent with previous data from our laboratory [12] and others [4, 47, 48], we demonstrated that intracerebroventricular oxytocin administration reduced measures of anxiety- and depression-like behavior in male and female mice. This evidence concerns the gene OXT and depressive symptom measurement.